GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
bacitracin A is an approved drug (FDA (1948))
Compound class:
Natural product
Comment: Bacitracin A is a polypeptide antibacterial with activity against Gram-positive bacteria. It is the major component of bacitracin [2], a mixture of at least nine closely-related cyclic polypeptides produced by Bacillus licheniformis and Bacillus subtilis.
|
|
No information available. |
Summary of Clinical Use ![]() |
Bacitracin is used principally in topical formulations for the treatment of minor skin wounds and eye infections, often in combination with other antibacterials including polymyxin B and neomycin. It is widely approved, although in some countries this may be for veterinary use only. See Drugs.com's International Drug Names list for further information. |
External links ![]() |
For extended ADME data see the following: Drugs.com |